2025/2568(RSP)

Presentation of the proposal on Critical Medicines Act (CMA)

Stage: Tabled for plenary, reached 11 Mar 2025
Procedure: Resolution
Last activity: 11 Mar 2025

1 entry · record as of 12 Oct 2026

Where it stands

Latest: Debate in plenary, 11 Mar 2025.

11 Mar 2025
- Debate in plenary

Summary

Generated

The Commission's Critical Medicines Act proposal targets chronic medicine shortages and EU reliance on foreign suppliers for essential drugs. It aims to strengthen domestic production and diversify sourcing of critical medicines. It affects pharmaceutical manufacturers, national health authorities and supply-chain stakeholders.

What the workspace adds on this file

Everything above is the public record. In the workspace, subscribers see this file with their own layer on top.

Why it matters to you

What this file means for your organization, assessed against your own priorities.

What moved

When this file moves, it reaches your own briefing, with a link to its source.

Your contacts on it

Your team's contacts logged against this file: who you met, what was said and the next step.

A first draft

A statement, a member update or a meeting brief on this file, in your organization's voice, with its sources.

Sources: EP Legislative Observatory. Record as of 12 Oct 2026. Something wrong on this page? Report an error.

Request access

See this file with your own layer on top: why it matters to you, your contacts on it and a first draft. We’ll schedule a 20-minute walkthrough.

Hosted in the EU · Security →

By submitting, you agree to our privacy policy.